Although CBZ administration in HLA-A*31:01+ patients causes diseases such as MPE and DRESS, CBZ administration in HLA-B*57:01+ Europeans resulted in SJS/TEN disease phenotypes [24] as observed for HLA-B*15:02+ patients [11]. Here, HLA-A is linked to toxic epidermal necrolysis.